14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Jan 16, 2026
MNMD vs TEF: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Jan 16, 2026, Telefonica, S.A. (TEF) is the stronger overall head-to-head candidate over Mind Medicine (MindMed) Inc. Common Shares (MNMD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MNMD carries a Unified Composite Score of 63.1/100 (BUY) at $15.02 (N/M Forward P/E, 0.0% operating margin), whereas TEF carries 56.8/100 (HOLD) at $3.81 (15.6x Forward P/E, 13.0% operating margin).
Composite vs. Pillar Nuance: While MNMD currently prints a higher short-term Unified Composite Score (63.1/100 BUY vs. TEF 56.8/100 HOLD), TEF captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (13.0% vs. 0.0% operating margin) and revenue trajectory (-6.6% vs. +0.0% YoY).
Technical & Structure Timing Caution: MNMD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 65.3); meanwhile TEF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MNMD vs TEF. Trailing 12-month operating profitability (MNMD 0.0% vs TEF 13.0%) and valuation multiples (MNMD N/M vs TEF 15.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Telecom Services value chain with $21.5B market capitalization and 13.0% operating margin.
OpEx & R&D Reinvestment41.5% of Rev ($17.3B)
90D Engineering Disclosures0 Published
Investor FAQ MNMD vs TEF Key Questions & Quantitative Answers
As of Jan 16, 2026, Telefonica, S.A. (TEF) is the stronger overall head-to-head candidate over Mind Medicine (MindMed) Inc. Common Shares (MNMD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MNMD carries a Unified Composite Score of 63.1/100 (BUY) at $15.02 (N/M Forward P/E, 0.0% operating margin), whereas TEF carries 56.8/100 (HOLD) at $3.81 (15.6x Forward P/E, 13.0% operating margin). Composite vs. Pillar Nuance: While MNMD currently prints a higher short-term Unified Composite Score (63.1/100 BUY vs. TEF 56.8/100 HOLD), TEF captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (13.0% vs. 0.0% operating margin) and revenue trajectory (-6.6% vs. +0.0% YoY). Technical & Structure Timing Caution: MNMD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 65.3); meanwhile TEF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MNMD leads the Growth & Scale pillar: MNMD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with TEF at -6.6% YoY revenue growth and N/A YoY earnings growth on $41.6B TTM revenue (54.5% gross margin, 13.0% operating margin). On trailing 12-month operating scale, MNMD generates N/A in USD-normalized revenue versus $41.6B for TEF. In operating R&D and SG&A reinvestment, MNMD deploys N/A (0 90-day corporate R&D disclosures) versus 41.5% of Rev ($17.3B) (0 disclosures) for TEF.
TEF screens cheaper on headline valuation multiples. MNMD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TEF trades at 15.6x Forward P/E, 12.6x Trailing P/E, 0.34x PEG, and 0.5x EV/Revenue (22.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MNMD (-85.6% ROE) versus TEF (-2.3% ROE) capital efficiency.
In options market volatility and institutional positioning, MNMD carries 70.7% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.18x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.79β · 55% Vol realized risk). By comparison, TEF carries 40.4% implied volatility (47th %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 25% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jan 16, 2026. For educational research only; not investment advice.